Results 161 to 170 of about 8,530 (199)

Pulmonary alveolar proteinosis

Clinics in Chest Medicine, 2004
Pulmonary alveolar proteinosis (PAP) has been recognized for almost half a century. At least three separate pathophysiologic mechanisms may lead to the characteristic feature of PAP: the excessive accumulation of surfactant lipoprotein in pulmonary alveoli, with associated disturbance of pulmonary gas exchange. The prognosis for adult patients with PAP
Presneill, JJ   +3 more
openaire   +5 more sources

Pulmonary Alveolar Proteinosis

Radiology, 1969
Since the original description of pulmonary alveolar proteinosis in 1958 (19), more than 100 cases have been reported. This article indicates the wide spectrum of roentgenographic changes (other than the well known batwing appearance) by reference to 5 patients in the San Francisco area who were examined recently.
J M, Davidson, W M, Macleod
  +7 more sources

Pulmonary Alveolar Proteinosis

Respiration, 1974
A case of alveolar proteinosis of the lungs with sarcoidal reaction of the lymph nodes is reported. The diagnosis was established by histological examination of lung tissue secured during thoracotomy.
J, Kurgan, K, Smigla
openaire   +5 more sources

PULMONARY ALVEOLAR PROTEINOSIS

Annals of Internal Medicine, 1960
Excerpt Pulmonary alveolar proteinosis was first described by Rosen et al. in June, 1958.1We have had the opportunity to observe a patient with this disease, and wish to report the clinical, labora...
W R, EDMONDSON, J B, GERE
  +7 more sources

Pulmonary Alveolar Proteinosis

Critical Reviews in Computed Tomography, 2003
Case 1: A 52-year-old Caucasian retired police officer presented 3 years prior to diagnosis with the chief complaint of inability to exercise due to breathlessness. The patient was a long-distance walker who had given up this recreational activity due to dyspnea on exertion.
Bruce C, Trapnell   +2 more
openaire   +4 more sources

Pulmonary Alveolar Proteinosis

New England Journal of Medicine, 1958
WITHIN the past five years, and at an increasing rate within recent months, we have encountered 27 cases of a remarkable disease of the lung that consists of the filling of the alveoli by a PAS-positive proteinaceous material, rich in lipid. This material appears to be produced by the lining cells, which slough into the lumen, ultimately becoming ...
Samuel H. Rosen   +4 more
openaire   +3 more sources

Autoimmune Pulmonary Alveolar Proteinosis

American Journal of Respiratory and Critical Care Medicine, 2022
Autoimmune pulmonary alveolar proteinosis (PAP) is a rare disease characterized by myeloid cell dysfunction, abnormal pulmonary surfactant accumulation, and innate immune deficiency. It has a prevalence of 7-10 per million; occurs in individuals of all races, geographic regions, sex, and socioeconomic status; and accounts for 90% of all patients with ...
Cormac McCarthy   +2 more
openaire   +2 more sources

Pulmonary Alveolar Proteinosis Syndrome

Seminars in Respiratory and Critical Care Medicine, 2020
AbstractPulmonary alveolar proteinosis (PAP) is a syndrome characterized by progressive accumulation of pulmonary surfactant. This results in dyspnea, secondary pulmonary and systemic infection, and in some cases respiratory failure. PAP syndrome occurs in distinct diseases, classified according to pathogenetic mechanism; these include primary PAP (due
Alan, Kelly, Cormac, McCarthy
openaire   +2 more sources

Home - About - Disclaimer - Privacy